Targeted Mild Hypercapnia and Right Ventricular Function After OHCA

🗝️ Key Points

  • 🫀 This was a preplanned substudy of the single-center TAME trial involving comatose patients resuscitated from out-of-hospital cardiac arrest 
  • 📈 Contrary to the concern that hypercapnic acidosis and lower tidal volumes harm the right ventricle, the hypercapnia group had better echocardiographic RV systolic function during the intervention
  • 💧 Invasive hemodynamics pointed the same direction: higher cardiac index, stroke volume, RV stroke work index, and RV cardiac power output in the hypercapnia group
  • ⚰️ RV failure carried nearly triple the 6-month mortality risk and survival was numerically higher with hypercapnia, but not statistically significant after adjustment

📝 Introduction

Post-cardiac arrest resuscitation targets are a topic of much debate and study. The Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) trial was a randomized control trial published in 2023 that assessed neurologic outcomes with targeted mild hypercapnia vs normocapnia in patients with out-of-hospital cardiac arrest (OHCA) who achieved return of spontaneous circulation (ROSC) given data suggesting that mild hypercapnia may increase cerebral perfusion. There is evidence in the literature showing hypercapnia may reduce myocardial contractility, increase pulmonary vascular resistance (PVR), and promote right ventricular (RV) dysfunction.3 A preplanned subgroup analysis of the TAME trial was concurrently carried out that assessed the effect of mild hypercapnia vs normocapnia on RV function in patients with OHCA in coma with or without shock.

🧾 Paper

Melberg MB, et al. The Effects of Targeted Mild Hypercapnia on Right Ventricular Function After Out-of-Hospital Cardiac Arrest: A Substudy of the Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest Trial. Chest. 2026. PMID: 41297587

🔙PREVIOUSLY COVERED ON REBEL EM:

⚙️ What They Did

CLINICAL QUESTION

What are the differences in efficacy and safety of HFNC, NIPPV, and facemask oxygen for preoxygenation of patients who are critically ill requiring tracheal intubation?

📈 Results

💥 Critical Results

💪🏽 Strengths

  • Adequate randomization in prospective trial: given this was a subanalysis of a larger RCT with robust randomization protocol
  • Baseline characteristics: Although slightly less fluids were given to intervention group, baseline characteristics were overall well matched
  • Achievement of target values and differences in treatment groups: difference in PaCO2 between study arms after randomization was achieved in a timely manner
  • Thorough echocardiographic evaluation: echocardiographic RV function parameters were well chosen and performed by a cardiologist
  • Echocardiographic data corroborated with RHC: majority of enrolled patients had hemodynamic data from PA catheter to further correlate with ultrasound evaluation

⚠️ Limitations

  • Planned subanalysis of larger RCT with small sample size: only 111 patients were enrolled in the study and as this was a planned post hoc subanalysis, power calculations were not done to assess necessary enrollment to detect a prespecified difference
  • Blinding not possible: given the nature of the intervention, blinding to hypercapnia vs normocapnia to the treatment team was not possible, and the bedside echocardiographic assessments were also unblinded which may confound data interpretation
  • Concomitant enrollment in TTM2: as such, all patients were cooled to 33℃ and it is unknown what effect this had on the outcome
  • Single center enrollment: all patients enrolled in this trial were from a single academic center, this limiting generalizability 
  • Limitations of US evaluation: TAPSE was the only consistently obtained echo measurement given instances of difficult acoustic windows or necessitates of care
  • Measures of RV function were load dependent: as such, true mechanistic RV function could not be evaluated as this would have required more invasive measurement techniques not available at the bedside
  • Inconsistency of RHC: only 84 of 111 patients underwent RHC as it was not a standardized protocol to place PA catheters in enrolled patients
  • Delay in randomization in treatment group: this caused a five hour difference in time to first echocardiographical evaluation which may have impacted differences in findings, although RHC data (when obtained) showed that any differences seen were present throughout study period

 

🗣️ Discussion

  • Prior animal models and data in non-cardiac arrest patients have pointed towards negative effects on RV function in the setting of hypercapnia, thought to be predominantly from increases in PVR and subsequently RV afterload. The results of this study present data not only challenging this dogma, but hypothesis generating trends towards the opposite.
  • Data acquired through serial echocardiography and RHC measurements showed a trend towards improved RV function in mild hypercapnia when compared to normocapnia in the immediate post-arrest period
  • The authors attribute these findings to several hypothetical mechanisms:
    • Hypercapnia necessitates reduced tidal volumes and respiratory rates to decrease minute ventilation in order to achieve, and perhaps contributed to offloading the RV
    • The treatment arm received less fluids overall, which the authors say also may have contributed to decreased loading conditions on the RV, although the difference in net-positive fluid balance between the two groups was approximately 1L and, while reaching statistical significance, may not represent a meaningful clinical difference
  • While these are plausible mechanisms, load-independent measurements would have been helpful to assess RV function between groups and perhaps would have shed more light on underlying mechanistic physiology
  • Animal models have shown acidosis, either alone or combined with hypercapnia, when induced transiently during early reperfusion (which describes the immediate post-ROSC period well), improved the functional recovery of stunned myocardium and reduced myocardial infarct size. Proposed mechanisms for these findings in animal models include:3
    • Reduction in calcium loading by inhibition of calcium uptake in academic conditions and by hydrogen competing for intracellular calcium binding sites
    • Attenuation of inflammatory processes and reduction in free radical production
    • Increase in blood flow and a reduction in energy expenditure
    • Inhibition of mitochondrial permeability transitioning pore formation
  • The results of the adjusted Cox proportional hazard model showed consistency with larger data sets showing increased mortality with the presence of RV failure (regardless of PaCO2), though this was a secondary outcome that the study was not powered for
  • Additionally, in the same adjusted survival model, mortality was similar in hypercapnia and normocapnia groups regardless of RV function, potentially indicating mild hypercapnia may not be harmful. This is unsurprising given the same findings in the parent study (TAME trial)
  • Given the study design and number of enrolled patients, this is hypothesis-generating and additional large scale RCT data will be necessary to validate the findings of this article before consideration of integration into post-cardiac arrest care guidelines
  • Anecdotally I have not been able to correlate PaCO2 and pH with RV function specifically, likely due to the fact that post-cardiac arrest patients are some of the sickest patients we care for in the ED and the ICU and as such they tend to have multiorgan failure and hemodynamic instability that is multifactorial and difficult to pin to a singular mechanism such as RV failure
  • Every intervention we do has reverberating effects across organ systems, and while mild hypercapnia may have some positive effects on myocardial function, this may be counterbalanced elsewhere
  • The data from this study and its parent trial at the very least challenges the dogma regarding mild hypercapnia being detrimental in the post-cardiac arrest setting, and perhaps suggests aggressive correction of mild hypercapnia to achieve normocapnia may be unnecessary
  • That being said, if future data supports the findings in this study, there are likely scenarios where mild hypercapnia would be indicated such as in the setting of overt RV failure 

📘 Author's Conclusion

“Among patients resuscitated from OHCA, targeting mild hypercapnia compared with normocapnia was not associated with worsened RV function, but rather with less RV dysfunction and failure. RV failure was associated with increased 6-month mortality.”

💬 Our Conclusion

Despite the limitations of this planned prospective subanalysis, there is compelling data questioning the long held dogma of hypercapnia induced RV dysfunction in a OHCA patient population, and even a suggested trend towards relative improved RV function when compared to normocapnia. However, aggressive correction of mild hypercapnia in this patient population may not be necessary based on the data presented. Given the findings of the parent TAME trial, it is unsurprising that mild hypercapnia alone was not associated with increased mortality compared with normocapnia. The finding of increased mortality in the setting of RV failure (regardless of PaCO2) echoes prior data.

🚨 Clinical Bottom Line

Mild hypercapnia in the first 24-hours after ROSC in OHCA is likely safe and may not require aggressive correction. Despite the data in this trial suggesting relative improvement of RV function in the setting of mild hypercapnia as compared to normocapnia, this is hypothesis-generating and requires further study prior to incorporation in standardized post-arrest care protocols.

📚 References

  1. Gevorgian H.
    “TAME Trial: Mild Hypercapnia vs Normocapnia in Out-of-Hospital Cardiac Arrest”, REBEL EM blog, August 21, 2023
    Full Blog Post Here

  2. Melberg MB, et al.
    The Effects of Targeted Mild Hypercapnia on Right Ventricular Function After Out-of-Hospital Cardiac Arrest: A Substudy of the Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest Trial. Chest. 2026;170(1):105-117.
    PMID: 41297587

  3. Crystal GJ.  
    Carbon Dioxide and the Heart. Anesthesia & Analgesia. 2015
    PMID: 26287294

  4. Eastwood G, et al.
    Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest. N Engl J Med. 2023;389(1):45-57.
    PMID: 37318140

Post Peer Reviewed By: Mark Ramzy, DO (X: @MRamzyDO)

👤 Guest Author

🔎 Your Deep-Dive Starts Here

Showing Slide 1 of 5: TAME Trial: Mild Hypercapnia vs Normocapnia in Out-of-Hospital Cardiac Arrest
Cite this article as: Jad Dandashi, MD, MPH, "Targeted Mild Hypercapnia and Right Ventricular Function After OHCA", REBEL EM blog, November 16, 2026. Available at: https://rebelem.com/hypercapnia-on-rv/.
Don’t Miss a Post – Follow Us
Want to support rebelem?
Get new posts (free)

1 email per week. No spam.

rebelSWAG-lightbg

Sponsored